Further Setback For Argentine Patent Law

28 May 1995

The Argentine Senate has partly overruled President Carlos Menem's veto of controversial new patent legislation.

In April, President Menem sent the draft law back to Congress "with observations," or an effective veto after pressure from the USA, including sanctions, which felt the law would discriminate against its drug industry in the Argentine market (Marketletter May 1). The Senate said it was insisting on an article deferring patent protection for drugs until 2003, but accepted the president's objections to an article which would have required local manufacture of foods which receive patent protection. The law now goes back to the lower House.

President Menem's brother Eduardo presides over the Senate.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight